Results 121 to 130 of about 272,115 (210)

Management of diabetic macular edema: from anti-VEGF to emerging therapies. [PDF]

Front Med (Lausanne)
Ji M, Wei W, Gong H, Zhang G.
europepmc   +1 more source

Reassessing high-dose ranibizumab in the era of durable anti-VEGF therapy. [PDF]

Front Ophthalmol (Lausanne)
Cheng CK, Tsai CJ, Bai CH.
europepmc   +1 more source

Clearing the bar: adding anti-VEGF therapy to chemoimmunotherapy for biliary tract cancer. [PDF]

J Gastrointest Oncol
King G, Sahai V.
europepmc   +1 more source

Factors Involved in Anti-VEGF Treatment Decisions for Neovascular Age-Related Macular Degeneration: Insights from Real-World Clinical Practice

Clinical Ophthalmology
Glenn Yiu,1 Shilpa Gulati,2 Victoria Higgins,3 Emily Coak,3 Daniel Mascia,3 Eunice Kim,4 Galin Spicer,4 David Tabano4 1Department of Ophthalmology & Vision Science, University of California, Davis Health, Sacramento, CA, USA; 2New England Retina ...
Yiu G, Gulati S, Higgins V, Coak E, Mascia D, Kim E, Spicer G, Tabano D   +7 more
doaj  

Eye Drop Development of Anti-VEGF Therapeutics by Ocular Penetrating Carrier to the Posterior Region of the Eye. [PDF]

Transl Vis Sci Technol
Chiueh VC, Lee LL, Tau S, Luu M, Park JH, Lee T.   +5 more
europepmc   +1 more source

Effects of anti-VEGF therapy on choroidal thickness in eyes with diabetic macular edema. [PDF]

BMC Ophthalmol
Shi XN, Zhang QY, Ju CJ, Xu YC, Xiong ZH.   +4 more
europepmc   +1 more source

Impact of Comorbid Hypertension and Diabetes on Anti-VEGF Treatment Outcomes in Macular Edema. [PDF]

J Ophthalmol
Lu W, Yang S, Zheng C, Wu Z.
europepmc   +1 more source

Suboptimal Responses to Anti-VEGF in Retinal Neurovascular Diseases: Linking Aging and Alternative Angioinflammatory Pathways. [PDF]

Invest Ophthalmol Vis Sci
Piroozmand S, Latifi-Navid H, Soheili ZS, Hosseinkhani S, Samiei S, Barzegar Behrooz A, Ahmadieh H, Leonardi A, Ghavami S, Sheibani N.   +9 more
europepmc   +1 more source

Anti-VEGF safety in evolution: A comprehensive review of ocular and systemic considerations. [PDF]

Indian J Ophthalmol
Venkatesh R, Biradar P, Malwe G, Prabhu V, Hande P, Kathare R, Raj P, Roy R, Yadav NK, Jayadev C.   +9 more
europepmc   +1 more source

Combined anti-VEGF approach in neovascular glaucoma: clinical outcomes of intracameral and intravitreal bevacizumab administration. [PDF]

BMC Ophthalmol
Çınar AC, Çınar AK, Sakallıoğlu AK, Garip R, Güçlü H.   +4 more
europepmc   +1 more source